Holen Sie sich die Stockscreener-App
55.86
0.07%
-0.04
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BMY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Bristol Myers Squibb Co Aktie (BMY) Neueste Nachrichten
Did UBS’s Pipeline-Driven Upgrade Just Shift Bristol-Myers Squibb’s (BMY) Investment Narrative? - Yahoo Finance UK
BMY Rallies 17.3% in Six Months: Buy, Sell or Hold the Stock? - TradingView — Track All Markets
Scotiabank raises Bristol-Myers Squibb stock price target to $60 on growth - Investing.com
Next Level Private LLC Has $2.54 Million Position in Bristol Myers Squibb Company $BMY - MarketBeat
Scotiabank Adjusts Price Target on Bristol-Myers Squibb to $60 From $53, Maintains Sector Perform Rating - MarketScreener
Is Bristol Myers Squibb Company Celegne Contingent stock attractive post correctionMarket Performance Report & Consistent Growth Equity Picks - ulpravda.ru
Will Bristol Myers Squibb Company stock outperform foreign stocksJuly 2025 PostEarnings & Weekly High Return Stock Forecasts - ulpravda.ru
The Escalator: Argenx, Gilead Sciences, Bristol Myers Squibb and more - Medical Marketing and Media
BMS-partnered ADC shows first Phase III success in hard-to-treat cancer - The Pharma Letter
Is Bristol Myers Squibb (BMY) Quietly Recasting Its Post-Patent Story With Opdivo And KarXT Moves? - simplywall.st
Bristol-Myers' buy of Celgene gets endorsement from top Wall Street advisory firms - The Pharma Letter
Assessing Bristol Myers Squibb (BMY) Valuation As Shares Gain And Profitability Narrative Evolves - Yahoo Finance UK
Bristol Myers Squibb Co. stock outperforms competitors on strong trading day - MarketWatch
3 Drug Stocks to Buy at a Discount - Finviz
Amgen Buys Dark Blue In $840 Million Bet On New Leukemia Drugs - Benzinga
Bristol-Myers Squibb (BMY) Upgraded to Buy with Raised Price Tar - GuruFocus
Bristol-Myers Squibb stock upgraded to Buy at UBS on promising 2026 catalysts - Investing.com India
BMY Stock Quote Price and Forecast - CNN
Why Bristol Myers (BMY) is Poised to Beat Earnings Estimates Again - Finviz
Bristol-Myers Squibb Earns ENERGY STAR® Partner of the Year Award for Third Consecutive Year - CSRwire
Bristol Myers Squibb Company $BMY Position Decreased by D.A. Davidson & CO. - MarketBeat
Areas of interest - Bristol-Myers Squibb Company
Is Bristol Myers Squibb a buy, sell, or hold in 2026? - MSN
Myocardial Infarction Market Is Booming Worldwide 2025-2032 | - openPR.com
Bristol-Myers Squibb (BMY) Stock Analysis: Navigating Potential Upside In Healthcare Giants - DirectorsTalk Interviews
The Motley Fool: Dividends and a chance for growth - Dallas News
Bristol Myers Squibb: Deep-Value Pharma Play Or Value Trap As Wall Street Turns Cautious? - AD HOC NEWS
Biological Therapies for Cancer Global Markets Report 2025-2030: Merck, BMS, Roche, AstraZeneca, Joh - PharmiWeb.com
Decoding Bristol-Myers Squibb's Options Activity: What's the Big Picture? - Benzinga
Biological Therapies for Cancer Global Markets Report 2025-2030: Merck, BMS, Roche, AstraZeneca, Johnson & Johnson, and Novartis Drive Growth Through Pipeline Expansion and Strategic CollaborationsResearchAndMarkets.com - FinancialContent
How to watch Bristol Myers Squibb at a major healthcare conference live - Stock Titan
Bristol Myers Squibb Just Shocked Wall Street: Is BMY the Most Slept-On Stock Right Now? - AD HOC NEWS
List of 25 Acquisitions by Bristol-Myers Squibb (Jan 2026) - Tracxn
Looking Into Bristol-Myers Squibb Co's Recent Short InterestBristol-Myers Squibb (NYSE:BMY) - Benzinga
Ex-Dividend Reminder: Encompass Health, Bristol Myers Squibb and Federal Realty Investment Trust - Nasdaq
Is Trending Stock Bristol Myers Squibb Company (BMY) a Buy Now? - Yahoo Finance
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
Bristol-Myers Squibb stock edges higher as Wall Street drifts into year-end — what’s next for BMY - ts2.tech
Goldman Sachs Raises Bristol-Myers (BMY) Target, Keeps Neutral Rating - Finviz
BMY vs AMGN: Which Biotech Stock Is More Resilient Now? - Finviz
Is Bristol Myers Squibb a Buy, Sell, or Hold in 2026? - The Motley Fool
Got $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever - Finviz
Bristol-Myers Squibb Stock Finds a Floor as Wall Street Bets on a Late-Cycle Rebound - AD HOC NEWS
Diversified Trust Co Has $4.56 Million Stake in Bristol Myers Squibb Company $BMY - MarketBeat
Inside Bristol-Myers Squibb: How a Quiet Pharma Giant Is Re?Architecting the Future of Cancer and Im - AD HOC NEWS
What does Wall Street think about Bristol-Myers Squibb Company (BMY)? - MSN
What Does Wall Street Think About Bristol-Myers Squibb Company (BMY)? - Finviz
10 Best Affordable Healthcare Stocks to Buy Now - Insider Monkey
Bristol-Myers Squibb Stock: Defensive Pharma Giant Tests Investor Patience As Wall Street Turns Sele - AD HOC NEWS
Bristol Myers Squibb stock slips today as year-end trading thins and dividend date nears - ts2.tech
Bristol Myers Squibb (BMY) Stock: Weekend News, Analyst Targets, Dividend Update, and What to Watch Before Monday’s Open - ts2.tech
Bristol-Myers Squibb Charts a New Strategic Course with U.S. Government Pact - AD HOC NEWS
Bristol-Myers Squibb (BMY) Stock: Weekend Market Close, Fresh Institutional Filings, and What to Watch Before Monday’s Open - ts2.tech
Meyer Handelman Co. Sells 52,438 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Trust Co. of Toledo NA OH Increases Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol-Myers Squibb (BMY) Stock News, Forecasts and Outlook as of Dec. 25, 2025: Breyanzi FDA Win, Eliquis Medicaid Deal, and 2026 Catalysts - ts2.tech
1.87%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):